Patents Assigned to Pentixapharm AG
  • Humanized antibodies against Lewis Y
    Patent number: 12415864
    Abstract: The present invention pertains to humanized anti-Lewis Y antibodies which specifically bind to Lewis Y and do not show any cross-reactivity. Especially, the humanized anti-Lewis Y antibodies do not bind to Lewis b or any other blood group carbohydrate antigen. In particular, the present invention is directed to humanized anti-Lewis Y antibodies which are useful in the treatment of cancer.
    Type: Grant
    Filed: June 29, 2021
    Date of Patent: September 16, 2025
    Assignee: Pentixapharm AG
    Inventors: Antje Danielczyk, Johanna Gellert, Anke Flechner, Patrik Kehler